Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 31 Mar 2017
At a glance
- Drugs AI 401 (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 27 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 Jun 2017.
- 15 Jan 2016 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.